Metabolomics Biomarker Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: MC391FBB953EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Metabolomics Biomarker in Global, including the following market information:

Global Metabolomics Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Metabolomics Biomarker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Protein Marker Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Metabolomics Biomarker include Biocrates Life Sciences, Biomark Diagnostics, Chenomx, Creative Proteomics, Evotec, Human Metabolome Technologies, Merck, Metabolomic Diagnostics and Metabolon and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metabolomics Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metabolomics Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Metabolomics Biomarker Market Segment Percentages, by Type, 2021 (%)

• Protein Marker
• Nucleic Acid Marker

Global Metabolomics Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Metabolomics Biomarker Market Segment Percentages, by Application, 2021 (%)

• Toxicological studies
• Drug testing
• Cancer
• Cardiovascular disorders
• Neurological disorders
• Inborn errors of metabolism

Global Metabolomics Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Metabolomics Biomarker Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Metabolomics Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Metabolomics Biomarker revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biocrates Life Sciences
• Biomark Diagnostics
• Chenomx
• Creative Proteomics
• Evotec
• Human Metabolome Technologies
• Merck
• Metabolomic Diagnostics
• Metabolon
• Ovid Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Metabolomics Biomarker Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Metabolomics Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL METABOLOMICS BIOMARKER OVERALL MARKET SIZE

2.1 Global Metabolomics Biomarker Market Size: 2021 VS 2028
2.2 Global Metabolomics Biomarker Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Metabolomics Biomarker Players in Global Market
3.2 Top Global Metabolomics Biomarker Companies Ranked by Revenue
3.3 Global Metabolomics Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Metabolomics Biomarker Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metabolomics Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metabolomics Biomarker Players in Global Market
  3.6.1 List of Global Tier 1 Metabolomics Biomarker Companies
  3.6.2 List of Global Tier 2 and Tier 3 Metabolomics Biomarker Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Metabolomics Biomarker Market Size Markets, 2021 & 2028
  4.1.2 Protein Marker
  4.1.3 Nucleic Acid Marker
4.2 By Type - Global Metabolomics Biomarker Revenue & Forecasts
  4.2.1 By Type - Global Metabolomics Biomarker Revenue, 2017-2022
  4.2.2 By Type - Global Metabolomics Biomarker Revenue, 2023-2028
  4.2.3 By Type - Global Metabolomics Biomarker Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Metabolomics Biomarker Market Size, 2021 & 2028
  5.1.2 Toxicological studies
  5.1.3 Drug testing
  5.1.4 Cancer
  5.1.5 Cardiovascular disorders
  5.1.6 Neurological disorders
  5.1.7 Inborn errors of metabolism
5.2 By Application - Global Metabolomics Biomarker Revenue & Forecasts
  5.2.1 By Application - Global Metabolomics Biomarker Revenue, 2017-2022
  5.2.2 By Application - Global Metabolomics Biomarker Revenue, 2023-2028
  5.2.3 By Application - Global Metabolomics Biomarker Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Metabolomics Biomarker Market Size, 2021 & 2028
6.2 By Region - Global Metabolomics Biomarker Revenue & Forecasts
  6.2.1 By Region - Global Metabolomics Biomarker Revenue, 2017-2022
  6.2.2 By Region - Global Metabolomics Biomarker Revenue, 2023-2028
  6.2.3 By Region - Global Metabolomics Biomarker Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Metabolomics Biomarker Revenue, 2017-2028
  6.3.2 US Metabolomics Biomarker Market Size, 2017-2028
  6.3.3 Canada Metabolomics Biomarker Market Size, 2017-2028
  6.3.4 Mexico Metabolomics Biomarker Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Metabolomics Biomarker Revenue, 2017-2028
  6.4.2 Germany Metabolomics Biomarker Market Size, 2017-2028
  6.4.3 France Metabolomics Biomarker Market Size, 2017-2028
  6.4.4 U.K. Metabolomics Biomarker Market Size, 2017-2028
  6.4.5 Italy Metabolomics Biomarker Market Size, 2017-2028
  6.4.6 Russia Metabolomics Biomarker Market Size, 2017-2028
  6.4.7 Nordic Countries Metabolomics Biomarker Market Size, 2017-2028
  6.4.8 Benelux Metabolomics Biomarker Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Metabolomics Biomarker Revenue, 2017-2028
  6.5.2 China Metabolomics Biomarker Market Size, 2017-2028
  6.5.3 Japan Metabolomics Biomarker Market Size, 2017-2028
  6.5.4 South Korea Metabolomics Biomarker Market Size, 2017-2028
  6.5.5 Southeast Asia Metabolomics Biomarker Market Size, 2017-2028
  6.5.6 India Metabolomics Biomarker Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Metabolomics Biomarker Revenue, 2017-2028
  6.6.2 Brazil Metabolomics Biomarker Market Size, 2017-2028
  6.6.3 Argentina Metabolomics Biomarker Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Metabolomics Biomarker Revenue, 2017-2028
  6.7.2 Turkey Metabolomics Biomarker Market Size, 2017-2028
  6.7.3 Israel Metabolomics Biomarker Market Size, 2017-2028
  6.7.4 Saudi Arabia Metabolomics Biomarker Market Size, 2017-2028
  6.7.5 UAE Metabolomics Biomarker Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biocrates Life Sciences
  7.1.1 Biocrates Life Sciences Corporate Summary
  7.1.2 Biocrates Life Sciences Business Overview
  7.1.3 Biocrates Life Sciences Metabolomics Biomarker Major Product Offerings
  7.1.4 Biocrates Life Sciences Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.1.5 Biocrates Life Sciences Key News
7.2 Biomark Diagnostics
  7.2.1 Biomark Diagnostics Corporate Summary
  7.2.2 Biomark Diagnostics Business Overview
  7.2.3 Biomark Diagnostics Metabolomics Biomarker Major Product Offerings
  7.2.4 Biomark Diagnostics Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.2.5 Biomark Diagnostics Key News
7.3 Chenomx
  7.3.1 Chenomx Corporate Summary
  7.3.2 Chenomx Business Overview
  7.3.3 Chenomx Metabolomics Biomarker Major Product Offerings
  7.3.4 Chenomx Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.3.5 Chenomx Key News
7.4 Creative Proteomics
  7.4.1 Creative Proteomics Corporate Summary
  7.4.2 Creative Proteomics Business Overview
  7.4.3 Creative Proteomics Metabolomics Biomarker Major Product Offerings
  7.4.4 Creative Proteomics Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.4.5 Creative Proteomics Key News
7.5 Evotec
  7.5.1 Evotec Corporate Summary
  7.5.2 Evotec Business Overview
  7.5.3 Evotec Metabolomics Biomarker Major Product Offerings
  7.5.4 Evotec Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.5.5 Evotec Key News
7.6 Human Metabolome Technologies
  7.6.1 Human Metabolome Technologies Corporate Summary
  7.6.2 Human Metabolome Technologies Business Overview
  7.6.3 Human Metabolome Technologies Metabolomics Biomarker Major Product Offerings
  7.6.4 Human Metabolome Technologies Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.6.5 Human Metabolome Technologies Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Metabolomics Biomarker Major Product Offerings
  7.7.4 Merck Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Metabolomic Diagnostics
  7.8.1 Metabolomic Diagnostics Corporate Summary
  7.8.2 Metabolomic Diagnostics Business Overview
  7.8.3 Metabolomic Diagnostics Metabolomics Biomarker Major Product Offerings
  7.8.4 Metabolomic Diagnostics Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.8.5 Metabolomic Diagnostics Key News
7.9 Metabolon
  7.9.1 Metabolon Corporate Summary
  7.9.2 Metabolon Business Overview
  7.9.3 Metabolon Metabolomics Biomarker Major Product Offerings
  7.9.4 Metabolon Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.9.5 Metabolon Key News
7.10 Ovid Therapeutics
  7.10.1 Ovid Therapeutics Corporate Summary
  7.10.2 Ovid Therapeutics Business Overview
  7.10.3 Ovid Therapeutics Metabolomics Biomarker Major Product Offerings
  7.10.4 Ovid Therapeutics Metabolomics Biomarker Revenue in Global Market (2017-2022)
  7.10.5 Ovid Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Metabolomics Biomarker Market Opportunities & Trends in Global Market
Table 2. Metabolomics Biomarker Market Drivers in Global Market
Table 3. Metabolomics Biomarker Market Restraints in Global Market
Table 4. Key Players of Metabolomics Biomarker in Global Market
Table 5. Top Metabolomics Biomarker Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metabolomics Biomarker Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metabolomics Biomarker Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metabolomics Biomarker Product Type
Table 9. List of Global Tier 1 Metabolomics Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metabolomics Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Metabolomics Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metabolomics Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metabolomics Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Metabolomics Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metabolomics Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metabolomics Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Metabolomics Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metabolomics Biomarker Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metabolomics Biomarker Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metabolomics Biomarker Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metabolomics Biomarker Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metabolomics Biomarker Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metabolomics Biomarker Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metabolomics Biomarker Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metabolomics Biomarker Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metabolomics Biomarker Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metabolomics Biomarker Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metabolomics Biomarker Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metabolomics Biomarker Revenue, (US$, Mn), 2023-2028
Table 30. Biocrates Life Sciences Corporate Summary
Table 31. Biocrates Life Sciences Metabolomics Biomarker Product Offerings
Table 32. Biocrates Life Sciences Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 33. Biomark Diagnostics Corporate Summary
Table 34. Biomark Diagnostics Metabolomics Biomarker Product Offerings
Table 35. Biomark Diagnostics Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 36. Chenomx Corporate Summary
Table 37. Chenomx Metabolomics Biomarker Product Offerings
Table 38. Chenomx Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 39. Creative Proteomics Corporate Summary
Table 40. Creative Proteomics Metabolomics Biomarker Product Offerings
Table 41. Creative Proteomics Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 42. Evotec Corporate Summary
Table 43. Evotec Metabolomics Biomarker Product Offerings
Table 44. Evotec Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 45. Human Metabolome Technologies Corporate Summary
Table 46. Human Metabolome Technologies Metabolomics Biomarker Product Offerings
Table 47. Human Metabolome Technologies Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Metabolomics Biomarker Product Offerings
Table 50. Merck Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 51. Metabolomic Diagnostics Corporate Summary
Table 52. Metabolomic Diagnostics Metabolomics Biomarker Product Offerings
Table 53. Metabolomic Diagnostics Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 54. Metabolon Corporate Summary
Table 55. Metabolon Metabolomics Biomarker Product Offerings
Table 56. Metabolon Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)
Table 57. Ovid Therapeutics Corporate Summary
Table 58. Ovid Therapeutics Metabolomics Biomarker Product Offerings
Table 59. Ovid Therapeutics Metabolomics Biomarker Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Metabolomics Biomarker Segment by Type in 2021
Figure 2. Metabolomics Biomarker Segment by Application in 2021
Figure 3. Global Metabolomics Biomarker Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metabolomics Biomarker Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metabolomics Biomarker Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metabolomics Biomarker Revenue in 2021
Figure 8. By Type - Global Metabolomics Biomarker Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metabolomics Biomarker Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metabolomics Biomarker Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metabolomics Biomarker Revenue Market Share, 2017-2028
Figure 12. US Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metabolomics Biomarker Revenue Market Share, 2017-2028
Figure 16. Germany Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 17. France Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metabolomics Biomarker Revenue Market Share, 2017-2028
Figure 24. China Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 28. India Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metabolomics Biomarker Revenue Market Share, 2017-2028
Figure 30. Brazil Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metabolomics Biomarker Revenue Market Share, 2017-2028
Figure 33. Turkey Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metabolomics Biomarker Revenue, (US$, Mn), 2017-2028
Figure 37. Biocrates Life Sciences Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Biomark Diagnostics Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Chenomx Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Creative Proteomics Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Evotec Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Human Metabolome Technologies Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Metabolomic Diagnostics Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Metabolon Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Ovid Therapeutics Metabolomics Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)